Cowper, P. A., Sheng, S., Anstrom, K. J., Stafford, J. A., Lopes, R. D., Davidson-Ray, L., … Mark, D. B. (2014). The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group. In CIRCULATION (Vol. 130). LIPPINCOTT WILLIAMS & WILKINS.

Cowper, Patricia A., Shubin Sheng, Kevin J. Anstrom, Judith A. Stafford, Renato D. Lopes, Linda Davidson-Ray, Lars Wallentin, et al. “The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group.” In CIRCULATION, Vol. 130. LIPPINCOTT WILLIAMS & WILKINS, 2014.

Cowper PA, Sheng S, Anstrom KJ, Stafford JA, Lopes RD, Davidson-Ray L, et al. The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2014.

Cowper, Patricia A., et al. “The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group.” CIRCULATION, vol. 130, LIPPINCOTT WILLIAMS & WILKINS, 2014.

Cowper PA, Sheng S, Anstrom KJ, Stafford JA, Lopes RD, Davidson-Ray L, Wallentin L, Phatak HM, Ansell J, Dorian P, Husted S, McMurray JJ, Steg PG, Alexander JH, Granger CB, Mark DB. The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2014.